GCTK Glucotrack
- 2.3629
- -0.1371-5.48%
- 2.7500
- +0.3871+16.38%
Glucotrack News
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Glucotrack To Carry Out 1-for-5 Reverse Stock Split On May 20th, 2024
May 17th - $Glucotrack(GCTK.US)$ is about to implement a 1-for-5 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from May 20th, 2024.$Glucotrack(GCTK.US)$ slippe
GlucoTrack Advances in Pioneering Glucose Monitoring Study
Glucotrack Announces Its Implantable Glucose Monitor Has Completed 30 Days Of A 60-Day Preclinical Study
Glucotrack Announces Its Implantable Glucose Monitor Has Completed 30 Days Of A 60-Day Preclinical Study
GLUCOTRACK'S EPIDURAL GLUCOSE MONITORING SENSOR DEMONSTRATES SUCCESSFUL 30-DAY SAFETY & PERFORMANCE IN LONG-TERM PRECLINICAL STUDY
Promising results support the potential of epidural glucose monitoring for simplified disease management for patients with painful diabetic neuropathyRutherford, NJ, May 16, 2024 — Glucotrack, Inc.
Glucotrack | 10-Q: Quarterly report
GlucoTrack: Reverse Stk Split Intended to Bring Stk Into Compliance With Nasdaq Minimum Bid Price Requirement >GCTK
GlucoTrack: Reverse Stk Split Intended to Bring Stk Into Compliance With Nasdaq Minimum Bid Price Requirement >GCTK
GlucoTrack Announces 1-for-5 Reverse Stk Split >GCTK
GlucoTrack Announces 1-for-5 Reverse Stk Split >GCTK
GLUCOTRACK ANNOUNCES REVERSE STOCK SPLIT
1-for-5 reverse stock split to become effective as of the opening of trading onMay 20, 2024Rutherford, NJ, May 15, 2024 — Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersNuwellis (NASDAQ:NUWE) shares rose 57.7% to $0.27 during Tuesday's regular session. The company's market cap stands at $4.1 million. As per the news, the Q1 earnings report came out today. Biov
GLUCOTRACK ANNOUNCES ABSTRACTS ACCEPTED FOR POSTER PRESENTATION AT 84TH SCIENTIFIC SESSIONS OF THE AMERICAN DIABETES ASSOCIATION
Continuous blood glucose monitor's preclinical data and sensor longevity modeling to be presented at major diabetes conferenceRutherford, NJ, May 02, 2024 — Glucotrack, Inc. (Nasdaq: GCTK) ("Glucot
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersCyclacel Pharmaceuticals (NASDAQ:CYCC) stock moved upwards by 50.0% to $2.04 during Tuesday's pre-market session. The company's market cap stands at $2.6 million. GeneDx Hldgs (NASDAQ:WGS) shar
12 Health Care Stocks Moving In Monday's After-Market Session
GainersGeneDx Hldgs (NASDAQ:WGS) shares increased by 21.8% to $13.4 during Monday's after-market session. The market value of their outstanding shares is at $349.1 million. The company's, Q1 earnings
GlucoTrack And 2 Other Stocks Under $1 Insiders Are Buying
The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inte
Director and 10% Owner Drew Sycoff Acquires 182,540 Shares of GlucoTrack Inc (GCTK)
Why Teledyne Technologies Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of Teledyne Technologies Incorporated (NYSE:TDY) fell sharply during Wednesday's session after the company reported worse-than-expected first-quarter financial results and cut FY24 adjusted EPS
Nasdaq Rises 0.5%; Tesla Shares Jump After Q1 Results
U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 0.5% on Wednesday.Following the market opening Wednesday, the Dow traded down 0.10% to 38,465.33 while the NASDAQ rose 0
GLUCOTRACK ANNOUNCES CLOSING OF PRIVATE PLACEMENT
Rutherford, NJ, April 22, 2024 — Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical device company focused on the design, development, and commercialization of novel technol
Glucotrack Announces Expansion Of Its Continuous Glucose Monitoring Technology To Epidural Glucose Monitoring
Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with Painful Diabetic NeuropathyRutherford, NJ, April 16, 2024 (GLOBE NEWSWIRE
GLUCOTRACK ANNOUNCES EXPANSION OF ITS CONTINUOUS GLUCOSE MONITORING TECHNOLOGY TO EPIDURAL GLUCOSE MONITORING
Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, announced that it is expanding its glucose monitoring technology to include measuring glucose in the epidural space.
Analysis
Price Target
No Data
